Swiss Startup Investments - Weekly recap (21-25.2.2022) - Week #8
B2B SaaS
Squirro: Undisclosed
Biotech
Aukera Therapeutics: CHF 500k
Stromal Therapeutics: CHF 500k
Engimmune Therapeutics: CHF 500k
SEED Biosciences: CHF 400k - Convertible Loan
FimmCyte: CHF 150k - Grant
Cleantech
Sympheny: Undisclosed
Shematic: CHF 100k - Convertible Loan
Cybersecurity
Tune Insight: CHF 150k - Grant
Foodtech
Rebels: Undisclosed - Seed
Marketplace/Pl…
Keep reading with a 7-day free trial
Subscribe to The Week in Swiss Startups to keep reading this post and get 7 days of free access to the full post archives.